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WITH the experience of over a quarter of a century of portacaval anastomosis,
it has been established that the operation prevents bleeding from oesophageal
varices, but there is still some doubt as to the therapeutic value of the pro-
cedure. A number of individual randomized controlled trials have failed to
demonstrate that either prophylactic or therapeutic portacaval shunt signifi-
cantly prolong life. However, if one combines the results of these trials, then
the superior survival of the shunted patient becomes significant (Conn, 1974).
Although the quantity of life may be greater, it is possible that the quality may
not. Certainly, the risk of recurrent haemorrhage is almost eliminated, but the
incidence and severity of portal systemic encephalopathy is undoubtedly in-
creased. The mode of dying is changed from one of terrifying torrential haemor-
rhage to one of drowsy drifting into delirium. In a small community like North-
ern Ireland, with relatively few patients with bleeding varices, a prospective
controlled trial is impractical, but some useful information can be obtained
from a retrospective study. This paper presents the results of a small personal
series of shunt operations over the ten year period ending December 1976.
PATIENT SURVEY
During the ten years reviewed, 58 shunts were carried out in 55 patients, of
whom 28 were male and 27 female. All patients have been followed up to the
time of death, or until the completion of this study, and of the survivors, only
three patients have been shunted for less than one year. Forty-six patients
with intra-hepatic block due to cirrhosis, had a total of 48 shunts, and the other
nine patients with extra-hepatic aetiology had 10 shunts (Table 1). It is pro-
posed to look at these two very different groups of patients separately.
TABLE I
All Shunts 1967-1976
End-to-Side Conventional Distal Mesenterico-
Block Patients Porta-Caval Spleno-Renal Spleno-Renal Caval
Intrahepatic 46 38 5 4 1




All 46 patients had needle or wedge biopsy of the liver, demonstrating macro-
nodular cirrhosis in 23, micro-nodular cirrhosis in 19, secondary biliary cirrhosisin 3, and Wilson's Disease in 1. In 14 patients, alcohol was considered the aetio-
logical factor; chronic active hepatitis was proven in 6 others, but was probably
the primary aetiology in many more. Three patients had associated sarcoidosis
of the liver, and in one, it appeared to be the main aetiological factor in the
production of the portal hypertension.
The mean age at the time of shunt was 48, with a range of 13-69 years. A)1 patients had bled from their varices on one to six occasions prior to shunt (mean
2.3). In almost half the patients, the acute haemorrhage had been controlled
by injection therapy initially, the shunt being carried out at a later date. Of the
48 shunts, only four were carried out as urgent procedures, that is, within 48
hours of the onset of bleeding; 21 were performed within four weeks of the last
haemorrhage, and the remainder at varying intervals up to one year. End-to-side
portacaval shunt, considered the procedure of choice, was used on 38 occa-
sions. Conventional spleno-renal shunt was used in five, distal spleno-renal shunt
in four, and H-graft mesenterico-caval shunt in one. Using Child's classification,
17 patients were Grade A, 15 patients Grade B, and 14 Grade C. There was only
one operative death in the series, and this occurred in a 31 year-old Child's
Grade C diabetic with jaundice and previous hepatic coma. Pre-operatively, he
required over 400 units of insulin daily, and following surgery, went into irrevers-
ible ketosis.
At the time of review, only 24 of the 46 patients were still surviving, but a
more meaningful figure is the five year survival of 50 per cent. The major cause





Haemorrhage 3 Blocked Conventional S/R Shunt
Blocked Distal S/R Shunt
Unrelated Causes 6
Unknown 1 Home Death
Post-Operative 1 Uncontrolled Ketosis
Total 22
but in only one did it result from a blocked portacaval shunt. This patient had
had organised thrombus removed from one wall of the portal vein at the time
of shunt, and following rebleeding nine weeks later, a successful conventional
splena-renal shunt was carried out. Two patients with conventional spleno-
renal shunts rebled; one due to a proven block, subsequently successfully treated
by mesenterico-caval H-graft. The other was a terminal haemorrhage in a patient
with presumed block and subsequent liver failure. One patient with a distal
spleno-renal shunt died from recurrent variceal haemorrhage three years after
114the primary operation, but shunt patency was not investigated. In the fifth
patient, fatal post-shunt bleeding was proven to be due to duodenal ulceration.
A more major morbidity was that of portal systemic encephalopathy. Of the
45 patients who survived surgery, 18 (40 per cent) had some symptoms of
encephalopathy, and 10 (22 per cent) required hospital admission on this account
on one or more occasions. About half of the patients who developed encephalo-
pathy did so within six months of the shunt, and it is of interest that some of
these patients appeared to develop tolerance to the state, improve clinically,
and subsequently continue with their occupation. About one-quarter to one-
third of Child's A and B cases developed encephalopathy, but almost two-
thirds of Grade C patients were affected. Incidence of encephalopathy in the
under 50 age group was low, but surprisingly, there was no difference in the
incidence in the 50-60 or 60-70 age groups (Table 3). Diabetics had a par-
ticularly high incidence of encephalopathy - 5 of the 6 diabetics in the series








under 50 16% (3/18)
50 - 60 53% (9/17)
60 - 70 54% (6/11)
Of the 14 patients with alcoholic cirrhosis, 7 returned to excess alcohol con-
sumption - a major factor in their deterioration or death.
NON-CIRRHOTIC GROUP
There were nine patients in the non-cirrhotic group. Eight had portal vein
thrombosis of varying degree, and one had a splenic arterio-venous fistula.
There were 6 males and 3 females in the group, with a mean age of 29 years
(range 10 - 53). One patient with intra-hepatic portal vein thrombosis had a
portacaval shunt, but at 14 months, rebleeding due to shunt thrombosis neces-
sitated conversion to conventional spleno-renal shunt. The others had splenectomy
and conventional end-to-side spleno-renal shunt. Only one patient with con-
ventional spleno-renal shunt had further bleeding, and this occurred soon after
the shunt - the patient has subsequently remained free from haemorrhage for
five and a half years to the time of review. There has been no post-shunt
encephalopathy, and no operative or delayed deaths in this group, now followed
up for from two months to ten years.
115DISCUSSION
One-half to one-third of patients with proven varices never bleed, but once
the first haemorrhage occurs, approximately two-thirds will rebleed within a
year, each episode carrying a high mortality. This high mortality is related
not only to the effects of hypovolaemia on an already sick liver, but also to the
associated circulatory, metabolic, renal and coagulation problems. Our approaoh
has been to try and control bleeding initially by conservative or relatively minor
surgical procedures, and then make every effort to improve the general clinical
status of these very ill patients over the next few weeks or months prior to
undertaking definitive surgery. Using oesophageal tamponade and injection
therapy, one can expect to save over 80 per cent of all patients with acute
variceal bleeding, and thus eliminate the need for emergency shunt. Orloff and
colleagues (1974) have been strong advocates of the emergency portocaval
shunt, but report a 52 per cent operative mortality, which we consider pro-
hibitive. Unfortunately, only one-quarter to one-third of the survivors of con-
servative management are ever considered fit for shunt, but the shunt rejects
can be satisfactorily managed by oesophageal transection using the SPTU
stapling gun (Van Kemmel, 1976; Johnston, 1977). Encouraging results with
this trans-abdominal method of transection have made us more selective in the
patients chosen for shunt, with the result that in the last year of the review,
only three patients were subjected to shunt. During the ten years reviewed, our
criteria for shunting have been less strict than in many centres, in that 11 of
the 46 cirrhotics (24 per cent) were aged 60 or over at the time of operation,
and 14 (30 per cent) were Child's Grade C patients. In spite of this, the operative
mortality in the cirrhotic group was only 2 per cent, and the five year survival 50
per cent. It looks as though no specific perimeters can be used consistently and
accurately to predict those patients who will do well with a conventional shunt
(Schwartz, 1975). Hepatic function tests may indicate the chance of early survival,
but do not predict the long-term outcome (Moody, 1975). In the past, I have
felt that "the patient who looked well and felt well, did well". Since Mikkelsen's
trial (1962), end-to-side portacaval shunt became the standard procedure in
most centres, conventional spleno-renal shunt or mesenterico-caval shunt being
reserved for the patient with portal vein block or previous surgery in the right
hypochondrium. The relatively new distal spleno-renal shunt, with its selective
decompression of the varices, is now challenging all other shunts because of low
incidence of post-shunt encephalopathy reported (Warren et al, 1967). However,
it is technically more difficult and carries a higher mortality than the other forms
of shunt, and we await with interest the results of an on-going controlled trial
(Salam et al, 1975). In this series, the occurrence of some degree of encephalo-
pathy in 40 per cent of the shunted patients, with severe symptoms in 22 per
cent, proved to be the main obstacle to return to full productive life. Its occur-
rence in four out of five diabetics, two-thirds of the Grade C patients, and over
one-half of the over 50's would encourage one to exclude these three categories
in any future selection of candidates for shunt.
Other complications attributed to portacaval shunt have included duodenal
ulcer, diabetes, and shunt thrombosis. Only four of the cirrhotics developed
116post-shunt duodenal ulcer, and this is no more than might be expected from a
samp!e of the general population of the same age and sex. Certainly, haemor-
rhage from an ulcer is poorly tolerated in these patients, and was the cause of
death in one patient. The severity of symptoms in one other patient with duo-
denal ulcer necessitated vagotomy and drainage three years after distal spleno-
renal shunt.
Diabetes is known to occur more commonly in cirrhotics than in non-cirrhotic
patients, but there is no conclusive evidence that portacaval anastomosis in-
creases the incidence (Conn, 1973). There were six diabetics in this series, but
none developed diabetes subsequent to the shunt.
Thrombosis of a portacaval shunt is unusual unless there is pre-existing throm-
bus in the portal vein, as occurred in both our patients with post-shunt throm-
bosis. In the Bristol series, 8 of 10 cirrhotics who had mural thrombus removed
at the time of shunt, subsequently developed thrombosis (Windle and Peacock,
1975). In retrospect, one would not advise portacaval shunt in this situation. The
thrombosis rate in conventional spleno-renal shunt is generally much higher,
due to the reversal of normal blood flow and the smaller vessel calibre. There
were two definite and one possible shunt thrombosis in the 14 conventional
spleno-renal shunts. Patients with portal vein thrombosis are said to be particu-
larly liable to blockage of their shunts, but in this group, there was only the one
possible failure just mentioned. Anyhow, where the liver function is normal and
the portal hypertension extra-hepatic in origin, the prognosis is good - there
were no deaths or portal systemic encephalopathy in the group during the ten
year period.
SUMMARY
In the ten years reviewed, 58 portal systemic shunts were performed in 55
patients with bleeding oesophageal varices, with only one operative death. In
the patients without cirrhosis, there was no encephalopathy or death. In the
cirrhotic group, the incidence of post-shunt encephalopathy was high (40 per
cent), and the five year survival low (50 per cent). End-to-side portacaval shunt
had a five per cent thrombosis rate compared to over 20 per cent for spleno-
renal shunt. Stricter criteria for shunt selection and more extensive use of
transabdominal oesophageal transection for the shunt rejects is advocated.
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